BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 27934110)

  • 1. Molecular Imaging Biosensor Monitors p53 Sumoylation in Cells and Living Mice.
    Sekar TV; Foygel K; Devulapally R; Kumar V; Malhotra S; Massoud TF; Paulmurugan R
    Anal Chem; 2016 Dec; 88(23):11420-11428. PubMed ID: 27934110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular imaging biosensor detects in vivo protein folding and misfolding.
    Sheahan AV; Sekar TV; Chen K; Paulmurugan R; Massoud TF
    J Mol Med (Berl); 2016 Jul; 94(7):799-808. PubMed ID: 27277823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of p53 signal pathway in lung cancer cell cycle arrest induced by cisplatin.
    Wang S; Li W; Xue Z; Lu Y; Narsinh K; Fan W; Li X; Bu Q; Wang F; Liang J; Wu K; Cao F
    Mol Carcinog; 2013 Nov; 52(11):900-7. PubMed ID: 22674879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protein folding molecular imaging biosensor monitors the effects of drugs that restore mutant p53 structure and its downstream function in glioblastoma cells.
    Paulmurugan R; Afjei R; Sekar TV; Babikir HA; Massoud TF
    Oncotarget; 2018 Apr; 9(30):21495-21511. PubMed ID: 29765555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast and sensitive quantification of protein SUMOylation using a dual luciferase biosensor.
    Zhang Y; Ke X; Liu Y; Zheng Z; Meng J; Wang H
    Analyst; 2017 Feb; 142(4):608-612. PubMed ID: 28138659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a cellular biosensor system for genotoxicity detection based on Trp53 promoter.
    Siqian L; Lei S; Ying L
    Hum Exp Toxicol; 2016 Oct; 35(10):1102-7. PubMed ID: 26721909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
    Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
    J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic monitoring of p53 translocation to mitochondria for the analysis of specific inhibitors using luciferase-fragment complementation.
    Noda N; Awais R; Sutton R; Awais M; Ozawa T
    Biotechnol Bioeng; 2017 Dec; 114(12):2818-2827. PubMed ID: 28832998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Firefly luciferase enzyme fragment complementation for imaging in cells and living animals.
    Paulmurugan R; Gambhir SS
    Anal Chem; 2005 Mar; 77(5):1295-302. PubMed ID: 15732910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High content screening biosensor assay to identify disruptors of p53-hDM2 protein-protein interactions.
    Hua Y; Strock CJ; Johnston PA
    Methods Mol Biol; 2015; 1278():555-65. PubMed ID: 25859976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging Histone Methylations in Living Animals.
    Sekar TV; Paulmurugan R
    Methods Mol Biol; 2016; 1461():203-15. PubMed ID: 27424907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen induces G3BP2 and SUMO-mediated p53 nuclear export in prostate cancer.
    Ashikari D; Takayama K; Tanaka T; Suzuki Y; Obinata D; Fujimura T; Urano T; Takahashi S; Inoue S
    Oncogene; 2017 Nov; 36(45):6272-6281. PubMed ID: 28692047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
    Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
    Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transgenic mouse model expressing an ERα folding biosensor reveals the effects of Bisphenol A on estrogen receptor signaling.
    Sekar TV; Foygel K; Massoud TF; Gambhir SS; Paulmurugan R
    Sci Rep; 2016 Oct; 6():34788. PubMed ID: 27721470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress.
    Brandl A; Wagner T; Uhlig KM; Knauer SK; Stauber RH; Melchior F; Schneider G; Heinzel T; Krämer OH
    J Mol Cell Biol; 2012 Oct; 4(5):284-93. PubMed ID: 22493095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated PKR inhibits pancreatic β-cell proliferation through sumoylation-dependent stabilization of P53.
    Song Y; Wan X; Gao L; Pan Y; Xie W; Wang H; Guo J
    Mol Immunol; 2015 Dec; 68(2 Pt A):341-9. PubMed ID: 26446704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
    Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and development of a whole-cell luminescent biosensor for detection of early-stage of apoptosis.
    Torkzadeh-Mahani M; Ataei F; Nikkhah M; Hosseinkhani S
    Biosens Bioelectron; 2012; 38(1):362-8. PubMed ID: 22770903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a highly inducible Gal4-->Fluc universal reporter mouse for in vivo bioluminescence imaging.
    Pichler A; Prior JL; Luker GD; Piwnica-Worms D
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15932-7. PubMed ID: 18843112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2-ARF complex regulates p53 sumoylation.
    Chen L; Chen J
    Oncogene; 2003 Aug; 22(34):5348-57. PubMed ID: 12917636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.